Both in Biotechnology
Vaxcyte vs Halozyme Therapeutics
Over the past year PCVX returned +37.0% and HALO returned +100.8%; their daily moves had a correlation of 0.12.
PCVX +37.0% HALO +100.8%Growth of $1, one year, split-adjusted
| Metric | PCVX | HALO |
|---|---|---|
| Price | $62.03 | $130.91 |
| Market cap | $9.76B | $14.86B |
| Today | −0.93% | −0.21% |
| 1 month | +10.7% | +22.4% |
| 6 months | +9.0% | +104.7% |
| Year to date | +34.4% | +94.5% |
| 1 year | +42.5% | +100.6% |
| Revenue growth (YoY) | — | +47.7% |
| Gross margin | — | 83.5% |
| Net margin | — | 47.8% |
| P/E (TTM) | — | 35.9× |
| Price / sales | — | 8.9× |
| Net cash | $1.49B | -$1.92B |
| Dividend yield | — | — |
| Volatility (60d) | 70.5% | 45.9% |
| Short % of float | 11.2% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).